Hydralazine's Effects on Blood Pressure and Heart Rate

Mechanism of Action and Cardiovascular Response

Hydralazine typically causes a reflex increase in sympathetic tone as a compensatory mechanism, leading to increased heart rate 1, and this effect can be mitigated by concurrent use of beta-blockers or other sympatholytic agents 2, 3, 4
The American College of Cardiology recommends using hydralazine with background diuretic and beta-blocker therapy due to its effect of increasing sympathetic tone and sodium retention 3, 4

In hypertensive emergencies, hydralazine begins to decrease blood pressure within 10-30 minutes, with effects lasting 2-4 hours 1, 5
The American Heart Association suggests that hydralazine is less desirable as a first-line agent for acute treatment in most patients due to the unpredictability of response and prolonged duration of action 5, 6
In resistant hypertension management, the American College of Cardiology recommends hydralazine as a fifth-line agent after other medications have failed to achieve blood pressure control 4, 7

The American College of Cardiology recommends keeping total daily doses of hydralazine below 150 mg to avoid drug-induced systemic lupus erythematosus 2
The use of hydralazine in combination with beta-blockers can minimize reflex tachycardia 2, 3

The American Heart Association recommends that hydralazine should not be used as monotherapy in myocardial infarction due to potential risks of provoking myocardial ischemia 8, 9
The American College of Cardiology recommends using hydralazine in combination with diuretics and beta-blockers in patients with heart failure, due to its effect of increasing sympathetic tone and sodium retention 8, 9
Hydralazine in combination with isosorbide dinitrate should be added to the regimen of diuretics, ACE inhibitors or ARBs, and beta-blockers in African American patients with heart failure with reduced ejection fraction, as it provides complementary effects: hydralazine causes arterial vasodilation and isosorbide dinitrate causes venous vasodilation 8, 9

The American College of Cardiology recommends keeping daily total doses of hydralazine below 150 mg to avoid drug-induced systemic lupus erythematosus 8, 9

The American College of Cardiology notes that hydralazine causes reflex tachycardia due to increased sympathetic tone as a compensatory response to arterial vasodilation, with palpitations and dizziness commonly occurring alongside the tachycardia, in patients taking hydralazine for hypertension 10, 11
Flushing is frequently reported due to the vasodilatory effects of hydralazine, particularly in patients with a history of cardiovascular disease 10, 11

The American Heart Association recommends that patients taking hydralazine be monitored for headache and gastrointestinal complaints, including nausea and vomiting, which are so prevalent that they represent the primary reason for treatment discontinuation at target doses, affecting a significant portion of patients with hypertension 12, 13
These side effects occur frequently enough to significantly impact medication compliance, highlighting the need for careful patient selection and monitoring 12, 13

The American College of Cardiology advises that a lupus-like syndrome is the most common immunologic side effect of hydralazine, particularly at higher doses, which is why total daily doses should be kept below 150 mg to minimize the risk of this adverse effect 11

The recommended target dose when the agents are prescribed separately is 40 mg isosorbide dinitrate three times daily (total 120 mg/day) and 75 mg hydralazine three times daily (total 300 mg/day) 14.
When given as a fixed‑dose combination, the target dose is 40 mg isosorbide dinitrate / 75 mg hydralazine three times daily 14.
The recommended starting dose for the fixed‑dose combination is 20 mg isosorbide dinitrate / 37.5 mg hydralazine three times daily 14.
In clinical trials, the mean doses actually achieved were approximately 90 mg isosorbide dinitrate and 175 mg hydralazine per day 14.
For separate prescriptions, the usual starting dose of isosorbide dinitrate is 20–30 mg taken three to four times daily, with a target total of 120 mg per day 14.
For separate prescriptions, the usual starting dose of hydralazine is 25–50 mg taken three to four times daily, with a target total of 300 mg per day 14.

In the African‑American Heart Failure Trial, adding the isosorbide dinitrate/hydralazine combination to optimal background therapy produced a 43 % relative risk reduction in all‑cause mortality (NNT = 25 over 10 months) in patients with NYHA class III–IV heart failure 14.
Even when sub‑maximal doses were used, the combination still conferred a statistically significant mortality benefit in the pivotal trials 14.

Adverse effects (primarily headache and dizziness) are the main reason many patients are unable to maintain target doses of the combination therapy [15][16]17.

Initiate therapy with the lower fixed‑dose combination (20 mg/37.5 mg three times daily) and increase the dose every 1–2 weeks as tolerated, aiming for the target dose of 40 mg/75 mg three times daily 14.